Data from Predictive Models for Toxicities after CAR T-cell Therapy: Challenges and Opportunities
Abstract Chimeric antigen receptor (CAR) T-cell therapy is increasingly utilized with expanding indications beyond hematologic malignancies. Here, we review existing models developed for predicting toxicities in the CAR T-cell setting and identify both strengths and challenges emerging with their application. Predictiv...
Julie Ma, August Culbert, Tiangen Chang et al.
· 0 citations